Schiedlberg

Researchers are investigating a new neurofeedback rehabilitation system called recoveriX PRO to help improve motor functions in people with Parkinsons Disease. This device combines brain-computer interface technology with motor imagination exercises, functional electrical stimulation FES, and virtual reality VR feedback. The study aims to compare the safety and effectiveness of recoveriX-based therapy to standard treatment using FES, VR, and motor imagery without monitoring brain activity. Participants are randomly assigned to one of two groups. The experimental group receives 24 sessions of brain-computer interface training with FES and VR feedback over four weeks, with six one-hour sessions per week. The control group receives the same number of sessions and therapy type but without the EEG cap that monitors brain signals. Both groups follow the same instructions during their therapy. Throughout the study, participants undergo detailed assessments before and after the intervention, including tests of motor skills, walking ability, fatigue, and the impact of Parkinsons on daily activities. Evaluations occur at weeks 0, 1, 5, and 7 using standardized scales such as the Unified Parkinsons Disease Rating Scale and several functional tests. This allows researchers to monitor changes in motor function and overall well-being, as well as the safety of the therapies over the study period.